Educational inequalities in multimorbidity at older ages: a multi-generational population-based study
European Journal of Public Health · 2024
DOI: 10.1093/eurpub/ckae096 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Public Health, 2024. Verfasst von Cornelia Wagner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Laboratory (#PopHealthLab), University of Fribourg, Fribourg, Switzerland. Hauptthemen laut MEDLINE: Multimorbidity, Educational Status. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Swiss National Science Foundation.
Abstract (Originalsprache)
Background
Social inequalities in multimorbidity may occur due to familial and/or individual factors and may differ between men and women. Using population-based multi-generational data, this study aimed to (1) assess the roles of parental and individual education in the risk of multimorbidity and (2) examine the potential effect modification by sex.
Methods
Data were analysed from 62 060 adults aged 50+ who participated in the Survey of Health, Ageing and Retirement in Europe, comprising 14 European countries. Intergenerational educational trajectories (exposure) were High–High (reference), Low–High, High–Low and Low–Low, corresponding to parental–individual educational attainments. Multimorbidity (outcome) was ascertained between 2013 and 2020 as self-reported occurrence of ≥2 diagnosed chronic conditions. Inequalities were quantified as multimorbidity-free years lost (MFYL) between the ages of 50 and 90 and estimated via differences in the area under the standardized cumulative risk curves. Effect modification by sex was assessed via stratification.
Results
Low individual education was associated with higher multimorbidity risk regardless of parental education. Compared to the High–High trajectory, Low–High was associated with −0.2 MFYL (95% confidence intervals: −0.5 to 0.1), High–Low with 3.0 (2.4–3.5), and Low–Low with 2.6 (2.3–2.9) MFYL. This pattern was observed for both sexes, with a greater magnitude for women. This effect modification was not observed when only diseases diagnosed independently of healthcare-seeking behaviours were examined.
Conclusions
Individual education was the main contributor to intergenerational inequalities in multimorbidity risk among older European adults. These findings support the importance of achieving a high education to mitigate multimorbidity risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Population Health Laboratory (#PopHealthLab), University of Fribourg, Fribourg, Switzerland.
- Swiss School of Public Health (SSPH+), University of Fribourg, Fribourg, Switzerland.
- Centre for Health Equity Studies, Stockholm University, Stockholm, Sweden.
- Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
- School of Population and Global Health, McGill University, Montreal, Canada.
- Quality of Care Service, University Hospitals of Geneva, Geneva, Switzerland.
ORCID-Profile: Arnaud Chiolero, Stéphane Cullati, Cristian Carmeli
Förderung
- NIA NIH HHS
- Swiss National Science Foundation
Zitieren
APA
Wagner, C., Jackisch, J., Ortega, N., Chiolero, A., Cullati, S., & Carmeli, C. (2024). Educational inequalities in multimorbidity at older ages: a multi-generational population-based study. European Journal of Public Health. https://doi.org/10.1093/eurpub/ckae096
Vancouver
Wagner C, Jackisch J, Ortega N, Chiolero A, Cullati S, Carmeli C. Educational inequalities in multimorbidity at older ages: a multi-generational population-based study. European Journal of Public Health. 2024. doi:10.1093/eurpub/ckae096
BibTeX
@article{Wagner2024,
author = {Wagner, Cornelia and Jackisch, Josephine and Ortega, Natalia and Chiolero, Arnaud and Cullati, Stéphane and Carmeli, Cristian},
title = {Educational inequalities in multimorbidity at older ages: a multi-generational population-based study},
journal = {European Journal of Public Health},
year = {2024},
doi = {10.1093/eurpub/ckae096}
}
EUVIMED